Association of American Cancer Institutes

About AACI

The Association of American Cancer Institutes (AACI) represents 106 of the leading academic and freestanding cancer research centers in North America. AACI is accelerating progress against cancer by enhancing the impact of academic cancer centers and promoting health equity.

Read The History of the Association of American Cancer Institutes, written in 2021 by Donald L. “Skip” Trump, MD, and Eric T. Rosenthal.

View AACI's statement on the public health crises of racism, discrimination, and violence.

Clinical Research Innovation

AACI's Clinical Research Innovation (CRI) provides a network for cancer center clinical research leaders to share best practices. Much of CRI’s activity is organized around an annual meeting attended by more than 400 clinical trials leaders from AACI cancer centers, industry representatives, and government agencies, who come together to address common challenges. Member services include access to active listservs, including a community outreach and engagement (COE) listserv, launched in 2021; and the opportunity to participate in working groups and task forces that focus on diversity, equity, and inclusion; staff retention; and the role of clinical trials office medical directors.

Physician Clinical Leadership

AACI’s Physician Clinical Leadership Initiative (PCLI) provides a forum for AACI cancer center physician leaders to promote cancer center clinical and quality care programs. PCLI addresses these interests through an annual meeting and by hosting webinars on a range of topics.


AACI/CCAF Annual Meeting

The AACI/CCAF Annual Meeting convenes hundreds of AACI cancer center members with leaders of national cancer research and advocacy groups, industry, and government health agencies. No other meeting presents information on cancer research and patient care as it directly pertains to academic cancer centers. It is also unique in providing cancer center leaders with a forum to discuss these issues and develop best practices with their peers.

CAR T Therapy

To advance the use of chimeric antigen receptor T-cell (CAR T) therapies use and establish best practices, AACI established the CAR T Initiative in 2018. AACI centers engage with the initiative through webinars, listserv discussions, calls, and meetings. Working groups focus on issues including clinical research and administrative barriers.

Government Relations

AACI’s public issues activity is guided in large part by the Government Relations (GR) Forum, which coordinates efforts among AACI cancer centers to educate legislators about the cancer research community and its positive impact on patients. The GR Forum also enhances understanding of policy issues pertaining to cancer prevention, treatment, clinical trials, and survivorship, and participates in a joint annual Hill Day with the American Association for Cancer Research (AACR).


Public Policy Resource Library

The AACI Public Policy Resource Library (PPRL) was the presidential initiative of Roy A. Jensen, MD, immediate past president of AACI. The PPRL enables cancer centers and others in the cancer advocacy community to share resources—including talking points and legislation enacted across the U.S.—to foster collaboration, promote cancer prevention, and spur the development of policies that will improve the lives of Americans through lowered cancer incidence and mortality. The PPRL also highlights federal legislation endorsed by AACI.

Mitigating Cancer Disparities

AACI aims to mitigate cancer disparities by leveraging cancer center expertise to convert understanding of those disparities into meaningful, measurable actions to improve patients’ lives. Results of an AACI survey on cancer center catchment areas were published in a 2022 paper about reducing the burden of cancer through community outreach and engagement.

Leadership Diversity and Development

Recognizing the urgent need for diversity in the oncology leadership pipeline, Caryn Lerman, PhD, is focusing her presidential initiative on leadership development for emerging cancer center leaders from diverse backgrounds. Dr. Lerman and her steering committee are developing a leadership diversity and development curriculum as well as best practices for mentoring and onboarding.

What do AACI cancer centers do?
AACI cancer centers are at the forefront of efforts to translate promising research findings into new interventions to prevent and treat cancer.

How do AACI cancer centers serve their communities?
AACI cancer centers offer their communities ready access to cancer experts, clinical trials, and novel therapies. They mitigate cancer health disparities through targeted community outreach and educational programming.

What are the benefits of NIH/NCI funding?
With funding from the National Institutes of Health (NIH) and the NCI, AACI cancer centers not only save lives, but generate biomedical jobs, which boost the economy. AACI cancer centers contribute to regional economic development by partnering with the pharmaceutical and biotechnology industries to create new opportunities to accelerate progress against cancer.

AACI institutions are largely funded by the NIH and the NCI, which rely on stable and predictable federal funding to invest in groundbreaking cancer research. AACI advocates on behalf of these institutions and for public policy initiatives that benefit the cancer center community.

Contact

Physical Address

Medical Arts Building
3708 Fifth Avenue, Suite 503
Pittsburgh, PA 15213
 

Mailing Address

PO Box 7317
Pittsburgh, PA 15213